Thus, HFE hemochromatosis patients (61) and Hfe−/− mice (62) express inappropriately low hepcidin levels and exhibit blunted hepcidin responses to iron intake (8, 63) due to defective BMP/SMAD signaling (64, 65). Here, HAMP is linked to hemochromatosis.